Cationic polymer based nanocarriers for delivery of therapeutic nucleic acids

Journal of Biomedical Nanotechnology

Volumn 7, Issue 4, 2011, Pages 504-520

  Nimesh, Surendra ^a   Gupta, Nidhi ^a   Chandra, Ramesh ^b,c  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b UNIVERSITY OF DELHI   (India)

^c UNIVERSITY OF DELHI   (India)

Author keywords

Cationic polymer; LNA; Nanocarriers; Nanoparticles; PNA; siRNA

Indexed keywords

CATIONIC POLYMERS; LNA; NANOCARRIERS; PNA; SIRNA;

FUNCTIONAL POLYMERS; NANOPARTICLES; NUCLEIC ACIDS; OLIGONUCLEOTIDES; TISSUE;

BIOMOLECULES;

ANTISENSE OLIGONUCLEOTIDE; LOCKED NUCLEIC ACID; NANOCARRIER; NANOPARTICLE; NUCLEIC ACID; PEPTIDE NUCLEIC ACID; PLASMID DNA; POLYMER; SMALL INTERFERING RNA; ANTISENSE OLIGODEOXYNUCLEOTIDE; CATION; DEOXYRIBOZYME; NANOCAPSULE; OLIGONUCLEOTIDE;

CYTOTOXICITY; DEGRADATION; GENE DELIVERY SYSTEM; GENETIC TRANSFECTION; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; NONHUMAN; PHAGOCYTOSIS; REVIEW; RNA INTERFERENCE; STATIC ELECTRICITY; ANIMAL; CHEMISTRY; DRUG DELIVERY SYSTEM; HUMAN; NANOTECHNOLOGY; PLASMID;

ANIMALS; CATIONS; DNA, CATALYTIC; DRUG DELIVERY SYSTEMS; HUMANS; NANOCAPSULES; NANOTECHNOLOGY; NUCLEIC ACIDS; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; OLIGONUCLEOTIDES; PEPTIDE NUCLEIC ACIDS; PLASMIDS; POLYMERS; RNA, SMALL INTERFERING;

EID: 80052870938     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2011.1313     Document Type: Review

References (158)

1. M. L. Stephenson and P. C. Zamecnik, Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide. Proc. Natl. Acad. Sci. USA 75, 285 (1978).
2. P. C. Zamecnik and M. L. Stephenson, Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide. Proc. Natl. Acad. Sci. USA 75, 280 (1978).
3. K. J. Scanlon, Anti-genes: siRNA, ribozymes and antisense. Curr. Pharm. Biotechnol. 5, 415 (2004).
4. D. Peer, J. M. Karp, S. Hong, O. C. Farokhzad, R. Margalit, and R. Langer, Nanocarriers as an emerging platform for cancer therapy. Nat. Nano 2, 751 (2007).
5. S. Mao, W. Sun, and T. Kissel, Chitosan-based formulations for delivery of DNA and siRNA. Adv. Drug Deliv. Rev. 62, 12 (2010).
6. D. Reischl and A. Zimmer, Drug delivery of siRNA therapeutics: Potentials and limits of nanosystems. Nanomedicine 5, 8 (2009).
7. E. Fattal, C. Vauthier, I. Aynie, Y. Nakada, G. Lambert, C. Malvy, and P. Couvreur, Biodegradable polyalkylcyanoacrylate nanoparticles for the delivery of oligonucleotides. J. Control Release 53, 137 (1998).
8. F. Alexis, E. Pridgen, L. K. Molnar, and O. C. Farokhzad, Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol. Pharm. 5, 505 (2008).
9. H. Potter, Electroporation in biology: Methods, applications, and instrumentation. Anal. Biochem. 174, 361 (1988).
10. L. M. Mir, M. F. Bureau, J. Gehl, R. Rangara, D. Rouy, J. M. Caillaud, P. Delaere, D. Branellec, B. Schwartz, and D. Scherman, High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc. Natl. Acad. Sci. USA 96, 4262 (1999).
11. H. Gao, W. Shi, and L. B. Freund, Mechanics of receptor-mediated endocytosis. Proc. Natl. Acad. Sci. USA 102, 9469 (2005).
12. H. Aoki, M. Satoh, K. Mitsuzuka, A. Ito, S. Saito, T. Funato, M. Endoh, T. Takahashi, and Y. Arai, Inhibition of motility and invasiveness of renal cell carcinoma induced by short interfering RNA transfection of beta 1, 4GalNAc transferase. FEBS Lett 567, 203 (2004).
13. M. Koping-Hoggard, Y. S. Mel'nikova, K. M. Varum, B. Lindman, and P. Artursson, Relationship between the physical shape and the efficiency of oligomeric chitosan as a gene delivery system in vitro and in vivo. J. Gene Med. 5, 130 (2003).
14. D. B. Rozema, D. L. Lewis, D. H. Wakefield, S. C. Wong, J. J. Klein, P. L. Roesch, S. L. Bertin, T. W. Reppen, Q. Chu, A. V. Blokhin, J. E. Hagstrom, and J. A. Wolff, Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes. Proc. Natl. Acad. Sci. USA 104, 12982 (2007).
15. D. W. Bartlett, H. Su, I. J. Hildebrandt, W. A. Weber, and M. E. Davis, Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging. Proc. Natl. Acad. Sci. USA 104, 15549 (2007).
16. H. Lee, H. Mok, S. Lee, Y. K. Oh, and T. G. Park, Target-specific intracellular delivery of siRNA using degradable hyaluronic acid nanogels. J. Control Release 119, 245 (2007).
17. S. A. Moschos, S. W. Jones, M. M. Perry, A. E. Williams, J. S. Erjefalt, J. J. Turner, P. J. Barnes, B. S. Sproat, M. J. Gait, and M. A. Lindsay, Lung delivery studies using siRNA conjugated to TAT(48-60) and penetratin reveal peptide induced reduction in gene expression and induction of innate immunity. Bioconjugate Chem. 18, 1450 (2007).
18. A. Muratovskaand and M. R. Eccles, Conjugate for efficient delivery of short interfering RNA (siRNA) into mammalian cells. FEBS Lett. 558, 63 (2004).
19. L. E. van Vlerken, T. K. Vyas, and M. M. Amiji, Poly(ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery. Pharm. Res. 24, 1405 (2007).
20. Z. Y. Zhang and B. D. Smith, High-generation polycationic dendrimers are unusually effective at disrupting anionic vesicles: Membrane bending model. Bioconjugate Chem. 11, 805 (2000).
21. O. Boussif, F. Lezoualch, M. A. Zanta, M. D. Mergny, D. Scherman, B. Demeneix, and J. P. Behr. A Versatile Vector for Gene and Oligonucleotide Transfer into Cells in Culture and in-Vivo-Polyethylenimine. Proc. Natl. Acad. Sci. USA 92, 7297 (1995).
22. M. Thomas, J. J. Lu, Q. Ge, C. Zhang, J. Chen, and A. M. Klibanov, Full deacylation of polyethylenimine dramatically boosts its gene delivery efficiency and specificity to mouse lung. Proc. Natl. Acad. Sci. USA 102, 5679 (2005).
23. M. Thomas and A. M. Klibanov, Enhancing polyethylenimine's delivery of plasmid DNA into mammalian cells. Proc. Natl. Acad. Sci. USA 99, 14640 (2002).
24. A. Akinc, M. Thomas, A. M. Klibanov, and R. Langer, Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis. J. Gene Med. 7, 657 (2005).
25. M. E. Dowty, P. Williams, G. Zhang, J. E. Hagstrom, and J. A. Wolff, Plasmid DNA entry into postmitotic nuclei of primary rat myotubes. Proc. Natl. Acad. Sci. USA 92, 4572 (1995).
26. K. Luby-Phelps, P. E. Castle, D. L. Taylor, and F. Lanni, Hindered diffusion of inert tracer particles in the cytoplasm of mouse 3T3 cells Proc. Natl. Acad. Sci. USA 84, 4910 (1987).
27. J. H. Jeong, S. W. Kim, and T. G. Park, Molecular design of functional polymers for gene therapy. Prog. Polym. Sc. 32, 1239 (2007).
28. M. Wilke, E. Fortunati, M. van den Broek, A. T. Hoogeveen, and B. J. Scholte, Efficacy of a peptide-based gene delivery system depends on mitotic activity. Gene Ther. 3, 1133 (1996).
29. H. Zhang, A. Mitin, and S. V. Vinogradov, Efficient Transfection of Blood-Brain Barrier Endothelial Cells by Lipoplexes and Polyplexes in the Presence of Nuclear Targeting NLS-PEG-Acridine Conjugates. Bioconjugate Chem. 20, 120 (2009).
30. J. Vacik, B. S. Dean, W. E. Zimmer, and D. A. Dean, Cell-specific nuclear import of plasmid DNA. Gene Ther. 6, 1006 (1999).
31. D. M. Lynn, M. M. Amiji, and R. Langer, pH-Responsive Polymer Microspheres: Rapid Release of Encapsulated Material within the Range of Intracellular pH. Angew Chem. Int. Ed. Engl. 40, 1707 (2001).
32. Y. Liu, D. Wu, Y. Ma, G. Tang, S. Wang, C. He, T. Chung, and S. Goh, Novel poly(amino ester)s obtained from Michael addition polymerizations of trifunctional amine monomers with diacrylates: Safe and efficient DNA carriers. Chem. Commun. 20, 2630 (2003).
33. N. Lavignac, M. Lazenby, P. Foka, B. Malgesini, I. Verpilio, P. Ferruti, and R. Duncan, Synthesis and endosomolytic properties of poly(amidoamine) block copolymers. Macromol. Biosci. 4, 922 (2004).
34. P. R. Dash, M. L. Read, L. B. Barrett, M. A. Wolfert, and L. W. Seymour, Factors affecting blood clearance and in vivo distribution of polyelectrolyte complexes for gene delivery. Gene Ther. 6, 643 (1999).
35. S. Nagayama, K. Ogawara, Y. Fukuoka, K. Higaki, and T. Kimura, Time-dependent changes in opsonin amount associated on nanoparticles alter their hepatic uptake characteristics. Int J. Pharm. 342, 215 (2007).
36. C. Fang, B. Shi, Y. Y. Pei, M. H. Hong, J. Wu, and H. Z. Chen, In vivo tumor targeting of tumor necrosis factor-alpha-loaded stealth nanoparticles: Effect of MePEG molecular weight and particle size. Eur. J. Pharm. Sci. 27, 27 (2006).
37. C. Brus, H. Petersen, A. Aigner, F. Czubayko, and T. Kissel, Efficiency of polyethylenimines and polyethylenimine-graft-poly(ethylene glycol) block copolymers to protect oligonucleotides against enzymatic degradation. Eur. J. Pharm. Biopharm. 57, 427 (2004).
38. M. Lee and S. W. Kim, Polyethylene glycol-conjugated copolymers for plasmid DNA delivery, Pharma. Res. 22, 1 (2005).
39. S. Akhtar and I. Benter, Toxicogenomics of non-viral drug delivery systems for RNAi: Potential impact on siRNA-mediated gene silencing activity and specificity. Adv. Drug Deliv. Rev. 59, 164 (2007).
40. W. T. Godbey, K. K. Wu, G. J. Hirasaki, and A. G. Mikos, Improved packing of poly(ethylenimine)/DNA complexes increases transfection efficiency. Gene Ther. 6, 1380 (1999).
41. W. T. Godbey, K. K. Wu, and A. G. Mikos, Poly(ethylenimine)- mediated gene delivery affects endothelial cell function and viability. Biomaterials 22, 471 (2001).
42. S. Ferrari, E. Moro, A. Pettenazzo, J. P. Behr, F. Zacchello, and M. Scarpa, ExGen 500 is an efficient vector for gene delivery to lung epithelial cells in vitro and in vivo. Gene Ther. 4, 1100 (1997).
43. C. Plank, K. Mechtler, F. C. Szoka, Jr., and E. Wagner, Activation of the complement system by synthetic DNA complexes: A potential barrier for intravenous gene delivery. Hum. Gene Ther. 7, 1437 (1996).
44. G. Borchard, Chitosans for gene delivery. Adv. Drug Del. Rev. 52, 145 (2001).
45. Y. Suzuki, Y. Okamoto, M. Morimoto, H. Sashiwa, H. Saimoto, S. I. Tanioka, Y. Shigemasa, and S. Minami, Influence of physicochemical properties of chitin and chitosan on complement activation. Carbohyd. Polym. 42, 307 (2000).
46. Y. Suzuki, K. Miyatake, Y. Okamoto, E. Muraki, and S. Minami, Influence of the chain length of chitosan on complement activation. Carbohyd. Polym. 54, 465 (2003).
47. A. Vaheri and J. S. Pagano, Infectious poliovirus RNA: A sensitive method of assay. Virology 27, 434 (1965).
48. W. T. Godbey, K. K. Wu, and A. G. Mikos, Poly(ethylenimine) and its role in gene delivery. J. Control Release 60, 149 (1999).
49. B. Abdallah, A. Hassan, C. Benoist, D. Goula, J. P. Behr, and B. A. Demeneix, A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: Polyethylenimine. Hum. Gene Ther. 7, 1947 (1996).
50. D. Goula, J. S. Remy, P. Erbacher, M. Wasowicz, G. Levi, B. Abdallah, and B. A. Demeneix, Size, diffusibility and transfection performance of linear PEI/DNA complexes in the mouse central nervous system. Gene Ther. 5, 712 (1998).
51. K. Kunath, A. von Harpe, D. Fischer, H. Petersen, U. Bickel, K. Voigt, and T. Kissel, Low-molecular-weight polyethylenimine as a non-viral vector for DNA delivery: Comparison of physicochemical properties, transfection efficiency and in vivo distribution with high-molecular-weight polyethylenimine. J. Control Release 89, 113 (2003).
52. L. Wightman, R. Kircheis, V. Rossler, S. Carotta, R. Ruzicka, M. Kursa, and E. Wagner, Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo. J. Gene Med. 3, 362 (2001).
53. W. T. Godbey, K. K. Wu, and A. G. Mikos, Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery. Proc. Natl. Acad. Sci. USA 96, 5177 (1999).
54. H. Kim, Y. M. Bae, H. A. Kim, H. Hyun, G. S. Yu, J. S. Choi, and M. Lee, Synthesis and characterization of dexamethasone-conjugated linear polyethylenimine as a gene carrier. J. Cell Biochem. 110, 743 (2010).
55. H. Hyun, J. Lee, D. W. Hwang, S. Kim, D. K. Hyun, J. S. Choi, J.-K. Lee, and M. Lee, Combinational therapy of ischemic brain stroke by delivery of heme oxygenase-1 gene and dexamethasone. Biomaterials 32, 306 (2011).
56. C. Hu, Q. Peng, F. Chen, Z. Zhong, and R. Zhuo, Low molecular weight polyethylenimine conjugated gold nanoparticles as efficient gene vectors. Bioconjug. Chem. 21, 836 (2010).
57. S. Son, D. W. Hwang, K. Singha, J. H. Jeong, T. G. Park, D. S. Lee, and W. J. Kim, RVG peptide tethered bioreducible polyethylenimine for gene delivery to brain. J. Control. Release doi:10.1016/j.jconrel.2010.08.011 (2010), In Press, Corrected Proof.
58. S. Nimesh, A. Goyal, V. Pawar, S. Jayaraman, P. Kumar, R. Chandra, Y. Singh, and K. C. Gupta, Polyethylenimine nanoparticles as efficient transfecting agents for mammalian cells. J. Control Release 110, 457 (2006).
59. S. Patnaik, A. Aggarwal, S. Nimesh, A. Goel, M. Ganguli, N. Saini, Y. Singh, and K. C. Gupta, PEI-alginate nanocomposites as efficient in vitro gene transfection agents. J. Control Release 114, 398 (2006).
60. S. Nimesh, A. Aggarwal, P. Kumar, Y. Singh, K. C. Gupta, and R. Chandra, Influence of acyl chain length on transfection mediated by acylated PEI nanoparticles. Int J. Pharm. 337, 265 (2007).
61. S. H. Pun, N. C. Bellocq, A. Liu, G. Jensen, T. Machemer, E. Quijano, T. Schluep, S. Wen, H. Engler, J. Heidel, and M. E. Davis, Cyclodextrin-modified polyethylenimine polymers for gene delivery. Bioconjug. Chem. 15, 831 (2004).
62. C. C. Yeh, H. L. Hsieh, J. Lee, Y. H. Jan, T. C. Lai, C. Y. Hong, M. Hsiao, and M. Y. Kuo, Polyethylenimine-mediated PUMA gene delivery to orthotopic oral cancer: Suppression of tumor growth through apoptosis induction in situ and prolonged survival. Head & Neck 33, 878 (2011).
63. A. Hu, X. Wu, Z. Li, H. Wang, J. Li, M. Yao, X. Chen, S. Qu, Y. Xu, and J. Gu. A novel gene delivery system targeting TiO2 for cancer gene therapy. Anticancer Res. 30, 1999 (2010).
64. G. Özgel and J. Akbuga, In vitro characterization and transfection of IL-2 gene complexes. Int J. Pharm. 315, 44 (2006).
65. F. C. MacLaughlin, R. J. Mumper, J. Wang, J. M. Tagliaferri, I. Gill, M. Hinchcliffe, and A. P. Rolland, Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery. J. Control Release 56, 259 (1998).
66. S. C. Richardson, H. V. Kolbe, and R. Duncan, Potential of low molecular mass chitosan as a DNA delivery system: Biocompatibility, body distribution and ability to complex and protect DNA. Int. J. Pharm. 178, 231 (1999).
67. Ü. Guliyeva, F. Öner, S. Özsoy, and R. Haziroglu, Chitosan microparticles containing plasmid DNA as potential oral gene delivery system. Eur. J. Pharm. Biopharm. 62, 17 (2006).
68. S. Mansouri, P. Lavigne, K. Corsi, M. Benderdour, E. Beaumont, and J. C. Fernandes, Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: Strategies to improve transfection efficacy. Eur. J. Pharm. Biopharm. 57, 1 (2004).
69. S. Mansouri, Y. Cuie, F. Winnik, Q. Shi, P. Lavigne, M. Benderdour, E. Beaumont, and J. C. Fernandes, Characterization of folate-chitosan-DNA nanoparticles for gene therapy. Biomaterials 27, 2060 (2006).
70. M. Lavertu, S. Methot, N. Tran-Khanh, and M. D. Buschmann, High efficiency gene transfer using chitosan/DNA nanoparticles with specific combinations of molecular weight and degree of deacetylation. Biomaterials 27, 4815 (2006).
71. P. L. Ma, M. Lavertu, F. M. Winnik, and M. D. Buschmann, New insights into chitosan-DNA interactions using isothermal titration microcalorimetry. Biomacromolecules 10, 1490 (2009).
72. T. Sato, T. Ishii, and Y. Okahata, In vitro gene delivery mediated by chitosan effect of pH, serum, and molecular mass of chitosan on the transfection efficiency. Biomaterials 22, 2075 (2001).
73. S. F. Peng, M. J. Yang, C. J. Su, H. L. Chen, P. W. Lee, M. C. Wei, and H. W. Sung, Effects of incorporation of poly(gamma-glutamic acid) in chitosan/DNA complex nanoparticles on cellular uptake and transfection efficiency. Biomaterials 30, 1797 (2009).
74. A. Bozkirand O. M. Saka, Chitosan-DNA nanoparticles: Effect on DNA integrity, bacterial transformation and transfection efficiency. J. Drug Target 12, 281 (2004).
75. P. Erbacher, S. Zou, T. Bettinger, A. M. Steffan, and J. S. Remy, Chitosan-based vector/DNA complexes for gene delivery: Biophysical characteristics and transfection ability. Pharm. Res 15, 1332 (1998).
76. S. Nimesh, M. M. Thibault, M. Lavertu, and M. D. Buschmann, Enhanced gene delivery mediated by low molecular weight chitosan/ DNA complexes: Effect of pH and serum. Mol. Biotechnol. 46, 182 (2010).
77. S. P. Strand, S. Lelu, N. K. Reitan, C. de Lange Davies, P. Artursson, and K. M. Varum, Molecular design of chitosan gene delivery systems with an optimized balance between polyplex stability and polyplex unpacking. Biomaterials 31, 975 (2010).
78. K. L. Chang, Y. Higuchi, S. Kawakami, F. Yamashita, and M. Hashida, Efficient gene transfection by histidine-modified chitosan through enhancement of endosomal escape. Bioconjugate Chem. 21, 1087 (2010).
79. H. L. Jiang, H. T. Lim, Y. K. Kim, R. Arote, J. Y. Shin, J. T. Kwon, J. E. Kim, J. H. Kim, D. Kim, C. Chae, J. W. Nah, Y. J. Choi, C. S. Cho, and M. H. Cho, Chitosan-graft-spermine as a gene carrier in vitro and in vivo. Eur. J. Pharm. Biopharm. 77, 36 (2011).
80. X. Zhao, L. Yin, J. Ding, C. Tang, S. Gu, C. Yin, and Y. Mao, Thiolated trimethyl chitosan nanocomplexes as gene carriers with high in vitro and in vivo transfection efficiency. J. Control Release 144, 46 (2010).
81. N. Csaba, M. Koping-Hoggard, E. Fernandez-Megia, R. Novoa- Carballal, R. Riguera, and M. J. Alonso, Ionically crosslinked chitosan nanoparticles as gene delivery systems: Effect of PEGylation degree on in vitro and in vivo gene transfer. J. Biomed. Nanotechnol. 5, 162 (2009).
82. N. D. Winblade, I. D. Nikolic, A. S. Hoffman, and J. A. Hubbell, Blocking adhesion to cell and tissue surfaces by the chemisorption of a poly-L-lysine-graft-(poly(ethylene glycol); phenylboronic acid) copolymer. Biomacromolecules 1, 523 (2000).
83. S. Parkand K. E. Healy, Nanoparticulate DNA packaging using terpolymers of poly(lysine-g-(lactide-b-ethylene glycol)). Bioconjugate Chemistry 14, 311 (2003).
84. Y. H. Choi, F. Liu, J. S. Kim, Y. K. Choi, J. S. Park, and S. W. Kim, Polyethylene glycol-grafted poly-L-lysine as polymeric gene carrier. J. Control Release 54, 39 (1998).
85. G. Liu, M. Molas, G. A. Grossmann, M. Pasumarthy, J. C. Perales, M. J. Cooper, and R. W. Hanson, Biological properties of poly- L-lysine-DNA complexes generated by cooperative binding of the polycation. J. Biol. Chem. 276, 34379 (2001).
86. M. Abbasi, H. Uludag, V. Incani, C. Olson, X. Lin, B. A. Clements, D. Rutkowski, A. Ghahary, and M. Weinfeld, Palmitic acid-modified poly-L-lysine for non-viral delivery of plasmid DNA to skin fibroblasts. Biomacromolecules 8, 1059 (2007).
87. V. Stanić, Y. Arntz, D. Richard, C. Affolter, I. Nguyen, C. Crucifix, P. Schultz, C. Baehr, B. Frisch, and J. Ogier. Filamentous condensation of DNA induced by pegylated poly-l-lysine and transfection efficiency. Biomacromolecules 9, 2048 (2008).
88. V. Incani, X. Lin, A. Lavasanifar, and H. Uludag, Relationship between the extent of lipid substitution on poly(L-lysine) and the DNA delivery efficiency. ACS Appl. Mater. Interfaces 1, 841 (2009).
89. Y. Liu, J. Li, K. Shao, R. Huang, L. Ye, J. Lou, and C. Jiang, A leptin derived 30-amino-acid peptide modified pegylated polyl- lysine dendrigraft for brain targeted gene delivery. Biomaterials 31, 5246 (2010).
90. M. Mousazadeh, A. Palizban, R. Salehi, and M. Salehi, Gene delivery to brain cells with apoprotein E derived peptide conjugated to polylysine (apoEdp-PLL). J. Drug Target 15, 226 (2007).
91. M. E. Davis and M. E. Brewster, Cyclodextrin-based pharmaceutics: Past, present and future. Nat. Rev. Drug. Discov. 3, 1023 (2004).
92. H. Gonzalez, S. J. Hwang, and M. E. Davis, New class of polymers for the delivery of macromolecular therapeutics. Bioconjugate. Chem. 10, 1068 (1999).
93. S. R. Popielarski, S. Mishra, and M. E. Davis, Structural effects of carbohydrate-containing polycations on gene delivery. 3. Cyclodextrin type and functionalization. Bioconjugate Chem. 14, 672 (2003).
94. T. M. Reinekeand M. E. Davis, Structural effects of carbohydrate- containing polycations on gene delivery. 2. Charge center type. Bioconjugate Chem. 14, 255 (2002).
95. T. M. Reineke and M. E. Davis, Structural effects of carbohydrate- containing polycations on gene delivery. 1. Carbohydrate size and its distance from charge centers. Bioconjugate Chem. 14, 247 (2002).
96. H. Huang, H. Yu, G. Tang, Q. Wang, and J. Li, Low molecular weight polyethylenimine cross-linked by 2-hydroxypropyl-gammacyclodextrin coupled to peptide targeting HER2 as a gene delivery vector. Biomaterials 31, 1830 (2010).
97. F. Kihara, H. Arima, T. Tsutsumi, F. Hirayama, and K. Uekama, Effects of structure of polyamidoamine dendrimer on gene transfer efficiency of the dendrimer conjugate with alpha-cyclodextrin. Bioconjug. Chem. 13, 1211 (2002).
98. F. Kihara, H. Arima, T. Tsutsumi, F. Hirayama, and K. Uekama, In vitro and in vivo gene transfer by an optimized alpha-cyclodextrin conjugate with polyamidoamine dendrimer. Bioconjug. Chem. 14, 342 (2003).
99. H. Yao, S. S. Ng, W. O. Tucker, Y.-K.-T. Tsang, K. Man, X.-M. Wang, B. K. C. Chow, H.-F. Kung, G.-P. Tang, and M. C. Lin, The gene transfection efficiency of a folate-PEI600-cyclodextrin nanopolymer. Biomaterials 30, 5793 (2009).
100. H. F. Gilbert, Thiol/disulfide exchange equilibria and disulfide bond stability. Methods Enzymol. 251, 8 (1995).
101. S. Raina and D. Missiakas, Making and breaking disulfide bonds. Annu. Rev. Microbiol. 51, 179 (1997).
102. M. A. Gosselin, W. Guo, and R. J. Lee, Efficient gene transfer using reversibly cross-linked low molecular weight polyethylenimine. Bioconjugate Chem. 12, 989 (2001).
103. Q. Peng, Z. Zhong, and R. Zhuo, Disulfide cross-linked polyethylenimines (PEI) prepared via thiolation of low molecular weight PEI as highly efficient gene vectors. Bioconjugate Chem. 19, 499 (2008).
104. M. Neu, O. Germershaus, S. Mao, K. H. Voigt, M. Behe, and T. Kissel, Crosslinked nanocarriers based upon poly(ethylene imine) for systemic plasmid delivery: In vitro characterization and in vivo studies in mice. J. Control Release 118, 370 (2007).
105. M. Neu, J. Sitterberg, U. Bakowsky, and T. Kissel, Stabilized nanocarriers for plasmids based upon cross-linked poly(ethylene imine). Biomacromolecules 7, 3428 (2006).
106. C. Lin, Z. Zhong, M. C. Lok, X. Jiang, W. E. Hennink, J. Feijen, and J. F. Engbersen, Novel bioreducible poly(amido amine)s for highly efficient gene delivery. Bioconjugate Chem. 18, 138 (2007).
107. D. G. Anderson, D. M. Lynn, and R. Langer, Semi-automated synthesis and screening of a large library of degradable cationic polymers for gene delivery. Angew. Chem. Int. Ed. Engl. 42, 3153 (2003).
108. C. Lin, C. J. Blaauboer, M. M. Timoneda, M. C. Lok, M. van Steenbergen, W. E. Hennink, Z. Zhong, J. Feijen, and J. F. Engbersen, Bioreducible poly(amido amine)s with oligoamine side chains: synthesis, characterization, and structural effects on gene delivery. J. Control Release 126, 166 (2008).
109. H. Zhang, A. Mitin, and S. V. Vinogradov, Efficient transfection of blood-brain barrier endothelial cells by lipoplexes and polyplexes in the presence of nuclear targeting NLS-PEG-acridine conjugates. Bioconjugate Chem. 20, 120 (2009).
110. H. Zhang and S. V. Vinogradov, Short biodegradable polyamines for gene delivery and transfection of brain capillary endothelial cells. J. Control Release 143, 359 (2010).
111. J. Z. Deng, Y. X. Sun, H. Y. Wang, C. Li, F. W. Huang, S. X. Cheng, R. X. Zhuo, and X. Z. Zhang, Poly(beta-amino amine) cross-linked PEIs as highly efficient gene vectors. Acta Biomater. 7, 2200 (2011).
112. H. Katas and H. O. Alpar, Development and characterisation of chitosan nanoparticles for siRNA delivery. J. Control Release 115, 216 (2006).
113. D. W. Lee, K. S. Yun, H. S. Ban, W. Choe, S. K. Lee, and K. Y. Lee, Preparation and characterization of chitosan/polyguluronate nanoparticles for siRNA delivery. J. Control Release 139, 146 (2009).
114. A. M. Ji, D. Su, O. Che, W. S. Li, L. Sun, Z. Y. Zhang, B. Yang, and F. Xu, Functional gene silencing mediated by chitosan/siRNA nanocomplexes. Nanotechnology 20, 405103 (2009).
115. M. Grzelinski, B. Urban-Klein, T. Martens, K. Lamszus, U. Bakowsky, S. Hobel, F. Czubayko, and A. Aigner, RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts. Hum. Gene Ther. 17, 751 (2006).
116. B. Urban-Klein, S. Werth, S. Abuharbeid, F. Czubayko, and A. Aigner, RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo. Gene Ther. 12, 461 (2005).
117. R. M. Schiffelers, A. Ansari, J. Xu, Q. Zhou, Q. Tang, G. Storm, G. Molema, P. Y. Lu, P. V. Scaria, and M. C. Woodle, Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle. Nucleic Acids Res. 32, e149 (2004).
118. S. Nimeshand R. Chandra, Polyethylenimine nanoparticles as an efficient in vitro siRNA delivery system. Eur. J. Pharm. Biopharm. 73, 43 (2009).
119. S. Höbel, I. Koburger, M. John, F. Czubayko, P. Hadwiger, H. P. Vornlocher, and A. Aigner, Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab. J. Gene Med. 12, 287 (2010).
120. S. Hobel, A. Loos, D. Appelhans, S. Schwarz, J. Seidel, B. Voit, and A. Aigner, Maltose- and maltotriose-modified, hyperbranched poly(ethylene imine)s (OM-PEIs): Physicochemical and biological properties of DNA and siRNA complexes. J. Control Release 149, 146 (2011).
121. S. Hu-Lieskovan, J. D. Heidel, D. W. Bartlett, M. E. Davis, and T. J. Triche, Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing's Sarcoma. Cancer Res. 65, 8984 (2005).
122. D. W. Bartlett and M. E. Davis, Impact of tumor-specific targeting and dosing schedule on tumor growth inhibition after intravenous administration of siRNA-containing nanoparticles. Biotechnol. Bioeng. 99, 975 (2008).
123. J. D. Heidel, Z. Yu, J. Y.-C. Liu, S. M. Rele, Y. Liang, R. K. Zeidan, D. J. Kornbrust, and M. E. Davis, Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA. Proc. Natl. Acad. Sci. USA 104, 5715 (2007).
124. M. E. Davis, J. E. Zuckerman, C. H. J. Choi, D. Seligson, A. Tolcher, C. A. Alabi, Y. Yen, J. D. Heidel, and A. Ribas, Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 464, 1067 (2010).
125. S. E. Han, H. Kang, G. Y. Shim, S. J. Kim, H. G. Choi, J. Kim, S. K. Hahn, and Y. K. Oh, Cationic derivatives of biocompatible hyaluronic acids for delivery of siRNA and antisense oligonucleotides. J. Drug Target 17, 123 (2009).
126. P. Vader, L. J. van der Aa, J. F. Engbersen, G. Storm, and R. M. Schiffelers, Disulfide-based poly(amido amine)s for siRNA delivery: Effects of structure on siRNA complexation, cellular uptake, gene silencing and toxicity. Pharm. Res. 28, 1013 (2011).
127. A. K. Varkouhi, T. Lammers, R. M. Schiffelers, M. J. van Steenbergen, W. E. Hennink, and G. Storm, Gene silencing activity of siRNA polyplexes based on biodegradable polymers. Eur. J. Pharm. Biopharm. 77, 450 (2011).
128. C. Q. Mao, J. Z. Du, T. M. Sun, Y. D. Yao, P. Z. Zhang, E. W. Song, and J. Wang, A biodegradable amphiphilic and cationic triblock copolymer for the delivery of siRNA targeting the acid ceramidase gene for cancer therapy. Biomaterials 32, 3124 (2011).
129. J. H. P. Chan, S. H. Lim, and W. S. F. Wong, Antisense oligonucleotides: From design to therapeutic application. Clin. Exp. Pharmacol. P 33, 533 (2006).
130. M. Manoharan, Oligonucleotide conjugates as potential antisense drugs with improved uptake, biodistribution, targeted delivery, and mechanism of action. Antisense and Nucleic Acid Drug Dev. 12, 103 (2002).
131. J. Kurreck, Antisense technologies - Improvement through novel chemical modifications. Eur. J. Biochem. 270, 1628 (2003).
132. O. Boussif, M. A. Zanta, and J. P. Behr, Optimized galenics improve in vitro gene transfer with cationic molecules up to 1000-fold. Gene Ther. 3, 1074 (1996).
133. W. T. Godbey and A. G. Mikos, Recent progress in gene delivery using non-viral transfer complexes. J. Control Release 72, 115 (2001).
134. S. V. Vinogradov, T. K. Bronich, and A. V. Kabanov, Self-assembly of polyamine-poly(ethylene glycol) copolymers with phosphorothioate oligonucleotides. Bioconjug. Chem. 9, 805 (1998).
135. H. Petersen, P. M. Fechner, D. Fischer, and T. Kissel. Synthesis characterization, and biocompatibility of polyethylenimine-graftpoly (ethylene glycol) block copolymers. Macromolecules 35, 6867 (2002).
136. E. M. Zaghloul, J. R. Viola, G. Zuber, C. I. E. Smith, and K. E. Lundin, Formulation and delivery of splice-correction antisense oligonucleotides by amino acid modified polyethylenimine. Mol. Pharm. 7, 652 (2010).
137. S. Sirsi, R. Schray, M. Wheatley, and G. Lutz, Formulation of polylactide-co-glycolic acid nanospheres for encapsulation and sustained release of poly(ethylene imine)-poly(ethylene glycol) copolymers complexed to oligonucleotides. J. Nanobiotech. 7, 1 (2009).
138. J. Wang, X. Tao, Y. Zhang, D. Wei, and Y. Ren, Reversion of multidrug resistance by tumor targeted delivery of antisense oligodeoxynucleotides in hydroxypropyl-chitosan nanoparticles. Biomaterials 31, 4426 (2010).
139. A. A. Koshkin, V. K. Rajwanshi, and J. Wengel, Novel convenient syntheses of LNA [2.2.1]bicyclo nucleosides. Tetrahedron Lett. 39, 4381 (1998).
140. C. Wahlestedt, P. Salmi, L. Good, J. Kela, T. Johnsson, T. Hokfelt, C. Broberger, F. Porreca, J. Lai, K. K. Ren, M. Ossipov, A. Koshkin, N. Jakobsen, J. Skouv, H. Oerum, M. H. Jacobsen, and J. Wengel, Potent and nontoxic antisense oligonucleotides containing locked nucleic acids. Proc. Natl. Acad. Sci. USA 97, 5633 (2000).
141. D. A. Braasch and D. R. Corey, Locked nucleic acid (LNA): Finetuning the recognition of DNA and RNA. Chem. Biol. 8, 1 (2001).
142. R. Crinelli, M. Bianchi, L. Gentilini, and M. Magnani, Design and characterization of decoy oligonucleotides containing locked nucleic acids. Nucleic Acids Res. 30, 2435 (2002).
143. J. Elmen, H. Thonberg, K. Ljungberg, M. Frieden, M. Westergaard, Y. H. Xu, B. Wahren, Z. C. Liang, H. Urum, T. Koch, and C. Wahlestedt, Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality. Nucleic Acids Res. 33, 439 (2005).
144. J. Kurreck, E. Wyszko, C. Gillen, and V. A. Erdmann, Design of antisense oligonucleotides stabilized by locked nucleic acids. Nucleic Acids Res. 30, 1911 (2002).
145. J. Wengel, Synthesis of 3′-C- and 4′-C-branched oligodeoxynucleotides and the development of locked nucleic acid (LNA). Acc. Chem. Res. 32, 301 (1999).
146. S. Obika, D. Nanbu, Y. Hari, J. Andoh, K. Morio, T. Doi, and T. Imanishi, Stability and structural features of the duplexes containing nucleoside analogues with a fixed N-type conformation, 2′-O,4′-C- methyleneribonucleosides. Tetrahedron Lett. 39, 5401 (1998).
147. S. Gao, F. Dagnaes-Hansen, E. J. B. Nielsen, J. Wengel, F. Besenbacher, K. A. Howard, and J. Kjems, The Effect of Chemical Modification and Nanoparticle Formulation on Stability and Biodistribution of siRNA in Mice. Mol. Ther. 17, 1225 (2009).
148. S. W. Santoro, G. F. Joyce, K. Sakthivel, S. Gramatikova, and C. F. Barbas, 3rd, RNA cleavage by a DNA enzyme with extended chemical functionality. J. Am. Chem. Soc. 122, 2433 (2000).
149. C. R. Dass, E. G. Saravolac, Y. Li, and L. Q. Sun, Cellular uptake, distribution, and stability of 10 deoxyribozymes. Antisense Nucleic Acid Drug Dev. 12, 289 (2002).
150. Y. Wu, L. Yu, R. McMahon, J. J. Rossi, S. J. Forman, and D. S. Snyder, Inhibition of bcr-abl oncogene expression by novel deoxyribozymes (DNAzymes). Human Gene Ther. 10, 2847 (1999).
151. S. H. Pun, F. Tack, N. C. Bellocq, J. Cheng, B. H. Grubbs, G. S. Jensen, M. E. Davis, M. Brewster, M. Janicot, B. Janssens, W. Floren, and A. Bakker, Targeted delivery of RNA-cleaving DNA enzyme (DNAzyme) to tumor tissue by transferrinmodified, cyclodextrin-based particles. Cancer Biol. Ther. 3, 641 (2004).
152. F. Tack, A. Bakker, S. Maes, N. Dekeyser, M. Bruining, C. Elissen- Roman, M. Janicot, M. Brewster, H. M. Janssen, B. F. De Waal, P. M. Fransen, X. Lou, and E. W. Meijer, Modified poly(propylene imine) dendrimers as effective transfection agents for catalytic DNA enzymes (DNAzymes). J. Drug Target 14, 69 (2006).
153. C. R. Dass, A. M. Friedhuber, L. M. Khachigian, D. E. Dunstan, and P. F. Choong, Biocompatible chitosan-DNAzyme nanoparticle exhibits enhanced biological activity. J. Microencapsul. 25, 421 (2008).
154. P. E. Nielsen, M. Egholm, R. H. Berg, and O. Buchardt, Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide. Science 254, 1497 (1991).
155. P. G. Millili, D. H. Yin, H. Fan, U. P. Naik, and M. O. Sullivan, Formulation of a peptide nucleic acid based nucleic acid delivery construct. Bioconjugate Chem. 21, 445 (2010).
156. K. Langer, C. Coester, C. Weber, H. von Briesen, and J. Kreuter, Preparation of avidin-labeled protein nanoparticles as carriers for biotinylated peptide nucleic acid. Eur. J. Pharm. Biopharm 49, 303 (2000).
157. K. W. Liang, E. P. Hoffman, and L. Huang, Targeted delivery of plasmid DNA to myogenic cells via transferrin-conjugated peptide nucleic acid. Mol. Ther. 1, 236 (2000).
158. H. Fang, K. Zhang, G. Shen, K. L. Wooley, and J. S. Taylor, Cationic shell-cross-linked knedel-like (cSCK) nanoparticles for highly efficient PNA delivery. Mol. Pharm. 6, 615 (2009).